Skip to main content
All lobbying filings

INCYTE CORPORATION

INCYTE CORPORATION filed a Q2 report for INCYTE CORPORATION on July 21, 2025.

Lobbying for INCYTE CORPORATION

All filings by INCYTE CORPORATION · Everything INCYTE CORPORATION has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$520,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Delaware

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Medicare/Medicaid

H.R. 946/S. 1862, Orphan Cures Act H.R. 1262, Give Kids a Chance Act Issues related to Medicaid rebates Issues related to Medicaid coverage of new drugs Issues related to implementation of the Inflation Reduction Act Issues related to drug cost and pricing Education around access to innovative therapies in dermatology

 Bills named in this filing 3

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem